Organoid-based systems for biomedical innovation: advances in disease modeling, drug screening, and precision medicine
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04848-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Aayush Prakash und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Organoids, Precision Medicine, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 220 Literaturangaben. Gefördert von: Northern Borders University.
Abstract (Originalsprache)
Organoid technology integrates stem-cell biology, biomaterials, and engineered culture platforms to recreate human tissue architecture with greater physiological relevance than 2D cultures or animal models. Advances in stem-cell differentiation and matrix design have facilitated the formation of complex, organ-specific 3D structures. This review presents the latest strategies for generating PSC and ASC-derived organoids, the role of biomaterials and microengineered systems in supporting their growth, and major applications in disease modeling and drug screening. Key translational challenges are also addressed in this manuscript. Stem-cell sources, scaffold materials, and platforms such as air-liquid interface systems and organoid-on-a-chip devices contribute significantly to structural and functional maturation. Organ-specific models across the brain, lung, intestine, liver, pancreas, stomach, and prostate are highlighted, along with ongoing limitations including insufficient vascularization, variability, and limited stromal or immune elements. Organoids represent promising human-relevant systems for biomedical research and therapeutic evaluation. Continued progress in biomaterials, microfluidics, and biobanking is strengthening their reproducibility, scalability, and translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. rishabhamalviya19@gmail.com.
- RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, United Arab Emirates.
- Department of Pathology, Faculty of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia.
Förderung
- Northern Borders University
Zitieren
APA
Prakash, A., Malviya, R., Sridhar, S. B., Othman, R. Q. A., Agarwal, A., Wadhwa, T., & Shareef, J. (2026). Organoid-based systems for biomedical innovation: advances in disease modeling, drug screening, and precision medicine. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04848-8
Vancouver
Prakash A, Malviya R, Sridhar SB, Othman RQA, Agarwal A, Wadhwa T, et al. Organoid-based systems for biomedical innovation: advances in disease modeling, drug screening, and precision medicine. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04848-8
BibTeX
@article{Prakash2026,
author = {Prakash, Aayush and Malviya, Rishabha and Sridhar, Sathvik Belagodu and Othman, Rashad Qasem Ali and Agarwal, Anshoo and Wadhwa, Tarun and Shareef, Javedh},
title = {Organoid-based systems for biomedical innovation: advances in disease modeling, drug screening, and precision medicine},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04848-8}
}
EUVIMED